Symposium on Quality of Life in Cancer PatientsGroup vs Individual Approaches to Understanding the Clinical Significance of Differences or Changes in Quality of Life
Section snippets
CRITERIA FOR CLINICAL SIGNIFICANCE
Unless one is willing to rely exclusively on distribution-based estimates of magnitude (eg, effect size), the identification of a CSD or clinically significant change requires one to identify a criterion (or at least an interpretable anchor) by which the significance of a change in respondent score is compared. One of the essential problems of patient-based health outcome measures, such as QOL indicators, is the position that a subjective perception of QOL or perceived health does not have a
Instrumentation and Measurement Standards
Instrumentation and measurement standards have been proposed to determine the usefulness of a particular instrument. There are several ways in which an instrument is potentially useful. It may be useful for individual diagnosis, group comparisons, or both. An instrument useful for individual diagnosis is rarely inappropriate for group comparisons; however, many instruments useful for group comparisons are inappropriate for individual diagnosis. Furthermore, within the realm of useful for group
Deductive Approaches
Still unresolved is the question of how group-level test results may be applied to individuals. Related is the question regarding the consequences of identifying an individual patient's status or change based on group data in terms of clinical meaningfulness. This topic can be discussed within the scenario of field studies, in which group-to-individual comparisons are necessary. One scenario could be to deductively interpret the results for an individual patient enrolled in a clinical trial
A COGNITIVE APPROACH TO CSD
Using the common deductive approach to clinical significance, group data are frequently used to provide an average estimate of an individual's view of CSD. In contrast, a cognitive perspective takes the inductive approach and asks how an individual judges CSD, and then uses this information to provide a model of a group measure CSD. When patients wish to assess the significance of a change in their health status, they usually compare and value some baseline estimate with their current health
CONCLUSIONS
Measuring QOL change is complex. If patients say they feel better from one assessment to the next (subjective anchor), they often, but not always, give higher QOL ratings in that second assessment. Similarly, patients who globally say they are doing worse at subsequent assessments tend, on average, to report worsened condition on an item-by-item basis. However, there is also substantial variability in the reporting of scores, including some patients who say they are better and report themselves
TOPICS FOR FURTHER STUDY
Further research is necessary to examine the extent to which individual and group criteria for clinical significance agree with one another. Currently, one is required to traverse the two with a degree of faith. It would also be useful to determine the conditions and circumstances that predict good fit between individual and group criteria. This could be investigated by assessing, in an epidemiological study or a clinical trial, multiple anchors for each individual and then comparing individual
REFERENCES (41)
- et al.
Methods to explain the clinical significance of health status measures
Mayo Clin Proc
(2002) - et al.
Measurement of health status: ascertaining the minimal clinically important difference
Control Clin Trials
(1989) - et al.
The St George's Respiratory Questionnaire
Respir Med
(1991) - et al.
Psychotherapy outcome research: methods for reporting variability and evaluating clinical significance
Behav Ther
(1984) - et al.
A method of assessing change in a single subject: an alteration of the RC index [letter]
Behav Ther
(1986) - et al.
Measuring change over time: assessing the usefulness of evaluative instruments
J Chronic Dis
(1987) - et al.
Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS)
Am J Cardiol
(1990) - et al.
Major depressive disorder in coronary artery disease
Am J Cardiol
(1987) “Proving the null hypothesis” in clinical trials
Control Clin Trials
(1982)- et al.
Measuring health status: what are the necessary measurement properties?
J Clin Epidemiol
(1992)
Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life
J Clin Epidemiol
Comparison of Rasch and summated rating scales constructed from SF-36 physical functioning items in seven countries: results from the IQOLA Project
J Clin Epidemiol
Use, misuse and abuse of questionnaires on quality of life
Patient Educ Couns
Individual-patient monitoring in clinical practice: are available health status surveys adequate?
Qual Life Res
Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol
Am J Respir Crit Care Med
Interpreting the significance of changes in health-related quality-of-life scores
J Clin Oncol
The meanings and measurement of clinical significance
J Consult Clin Psychol
Evaluating clinically significant differences in utility scores [abstract]
Qual Life Res
Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors
J Clin Oncol
Variability in outcome and clinical significance of behavioral marital therapy: a reanalysis of outcome data
J Consult Clin Psychol
Cited by (144)
Giving meaning to patient reported outcomes in breast reconstruction after mastectomy – A systematic review of available scores and suggestions for further research
2022, BreastCitation Excerpt :Therefore, we are obliged to make sure that the procedures are truly beneficial to our patients. Examples of more relevant ways to present results, to facilitate interpretation of the effect of different reconstructive options, could be clinically meaningful categories of change (improved/deteriorated/stable/uncertain) [5,28] or the proportion of patients who have reached predefined changes in scores. Another alternative is the number needed to treat (NNT), that is the average number of patients needed to achieve one patient with improved QoL according to a predefined level, for example according to percentiles of normative data.
Reduced quality of life in ICU survivors - the story behind the numbers: A mixed methods study
2021, Journal of Critical CareWhat Is a “Validated Questionnaire”? A Critical Review of Erectile Function Assessment
2020, Journal of Sexual Medicine
This project was supported in part by Public Health Service grants CA25224, CA37404, CA15083, CA35269, CA35113, CA35272, CA52352, CA35103, CA37417, CA63849, CA35448, CA35101, CA35195, CA35415, and CA35103.
Individual reprints of this article are not available. The entire Symposium on the Clinical Significance of Quality-of-Life Measures in Cancer Patients will be available for purchase as a bound booklet from the Proceedings Editorial Office at a later date.
A complete list of other Clinical Significance Consensus Meeting Group contributors to this article appears at the end of the article.